14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACRS
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Aclaris Therapeutics
(Updated on Jun 14, 2024)

Buy candidate since Jun 13, 2024 Loss -0.84% PDF

The Aclaris Therapeutics stock price fell by -0.84% on the last day (Friday, 14th Jun 2024) from $1.19 to $1.18. During the last trading day the stock fluctuated 6.93% from a day low at $1.15 to a day high of $1.23. The price has risen in 6 of the last 10 days and is up by 14.56% over the past 2 weeks. Volume has increased on the last day by 92 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $1.18 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.94% during the next 3 months and, with a 90% probability hold a price between $0.90 and $1.18 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ACRS Signals & Forecast

The Aclaris Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.11 and $1.16. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 13, 2024, and so far it has fallen -0.84%. Further fall is indicated until a new bottom pivot has been found. Aclaris Therapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Aclaris Therapeutics stock

Aclaris Therapeutics finds support from accumulated volume at $1.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0797 between high and low, or 6.93%. For the last week, the stock has had daily average volatility of 9.00%.

Our recommended stop-loss: $1.14 (-2.99%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 12 days ago.)

Trading Expectations (ACRS) For The Upcoming Trading Day Of Monday 17th

For the upcoming trading day on Monday, 17th we expect Aclaris Therapeutics to open at $1.19, and during the day (based on 14 day Average True Range), to move between $1.11 and $1.25, which gives a possible trading interval of +/-$0.0700 (+/-5.93%) up or down from last closing price. If Aclaris Therapeutics takes out the full calculated possible swing range there will be an estimated 11.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.19 (0.85%) than the support at $1.17 (0.85%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aclaris Therapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 1.565 Buy Candidate Unchanged

Predicted Opening Price for Aclaris Therapeutics of Monday, June 17, 2024

Fair opening price June 17, 2024 Current price
$1.19 ( 0.556%) $1.18

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACRS

Fibonacci Support & Resistance Levels

Level Price
R3 1.27 7.31%
R2 1.24 4.73%
R1 1.22 3.14%
Price 1.18
S1 1.16 -2.02%
S2 1.14 -3.62%
S3 1.11 -6.20%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.26 6.78%
R2 1.22 3.39%
R1 1.19 0.85%
Price 1.18
S1 1.17 -0.85%
S2 1.15 -2.54%
S3 1.05 -11.02%


What is the symbol for Aclaris Therapeutics Stock and on which exchange is it traded?
The symbol for Aclaris Therapeutics is ACRS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aclaris Therapeutics Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Aclaris Therapeutics Stock?
Aclaris Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aclaris Therapeutics Stock.

What's the current price of Aclaris Therapeutics Stock?
As of the end of day on the Jun 14, 2024, the price of an Aclaris Therapeutics (ACRS) share was $1.18.

What is the 52-week high and low for Aclaris Therapeutics Stock?
The 52-week high for Aclaris Therapeutics Stock is $11.12 and the 52-week low is $0.590.

What is the market capitalization of Aclaris Therapeutics Stock?
As of the Jun 14, 2024, the market capitalization of Aclaris Therapeutics is 84.092M.

When is the next earnings date for Aclaris Therapeutics?
The upcoming earnings date for Aclaris Therapeutics is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE